RMD – resmed inc. (US:NASDAQ)
Stock Stats
News
ResMed (RMD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
ResMed (RMD) was given a new $255.00 price target by Evercore Inc. They now have an "outperform" rating on the stock.
ResMed (RMD) had its price target lowered by Citigroup Inc. from $345.00 to $340.00. They now have a "buy" rating on the stock.
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Is It Time To Revisit ResMed (RMD) After Recent Share Price Weakness? [Yahoo! Finance]
Form 4 RESMED INC For: Apr 07 Filed by: Farrell Michael J.
Form 144 RESMED INC Filed by: Farrell Michael J.
Form 4 RESMED INC For: Apr 01 Filed by: Sandercock Brett
Form 4 RESMED INC For: Apr 01 Filed by: FARRELL PETER C
Form 144 RESMED INC Filed by: FARRELL PETER C
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.